Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study.

Moldofsky H, Patcai J. · 2011

Read Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. by Moldofsky H, Patcai J. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3071317.txt.

Introduction

Moldofsky and Patcai studied in 2011 the long shadow of SARS in Toronto patients who still could not return to work well over a year after infection. Most were health care workers. The team recorded their sleep in the lab and compared their symptoms with healthy volunteers and with patients who have fibromyalgia, a chronic pain and fatigue condition.

Survivors showed lasting fatigue, widespread muscle pain, weakness, low mood, and sleep that did not refresh. Their brain waves during sleep were unusually unstable, with breathing pauses tied to dream sleep. The pattern closely resembled fibromyalgia and chronic fatigue syndrome, with a few differences in pain and brain wave measures. The authors present chronic post SARS illness as its own syndrome overlapping both conditions. Their warning proved timely for later pandemics: surviving a severe virus can mean years of disability.

Catalog record

CREATORMoldofsky H, Patcai J.
YEAR2011
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3071317

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study By Harvey Moldofsky, John Patcai Published in: BMC Neurology DOI: 10.1186/1471-2377-11-37 ABSTRACT Background The long term adverse effects of Severe Acute Respiratory Syndrome (SARS), a viral disease, are poorly understood. Methods Sleep physiology, somatic and mood symptoms of 22 Toronto subjects, 21 of whom were healthcare workers, (19 females, 3 males, mean age 46.29 yrs.+/- 11.02) who remained unable to return to their former occupation (mean 19.8 months, range: 13 to 36 months following SARS) were compared to 7 healthy female subjects. Because of their clinical similarities to patients with fibromyalgia syndrome (FMS) these post-SARS subjects were similarly compared to 21 drug free female patients, (mean age 42.4 +/- 11.8 yrs.) who fulfilled criteria for fibromyalgia. Results Chronic post-SARS is characterized by persistent fatigue, diffuse myalgia, weakness, depression, and nonrestorative sleep with associated REM-related apneas/hypopneas, an elevated sleep EEG cyclical alternating pattern, and alpha EEG sleep anomaly. Post- SARS patients had symptoms of pre and post-sleep fatigue and post sleep sleepiness that were similar to the symptoms of patients with FMS, and similar to symptoms of patients with chronic fatigue syndrome. Both post-SARS and FMS groups had sleep instability as indicated by the high sleep EEG cyclical alternating pattern rate. The post-SARS group had a lower rating of the alpha EEG sleep anomaly as compared to the FMS patients. The post-SARS group also reported less pre-sleep and post-sleep musculoskeletal pain symptoms. Conclusions The clinical and sleep features of chronic post-SARS form a syndrome of chronic fatigue, pain, weakness, depression and sleep disturbance, which overlaps with the clinical and sleep features of FMS and chronic fatigue syndrome. BACKGROUND In light of public health concerns about the adverse effects of the recent H1N1 pandemic viral infection, it is noted that the long-term effects on survivors of those who survive severe illness are unknown. In this paper we report the results of our study of the long term adverse effects of Severe Acute Respiratory Syndrome (SARS) that emerged from South East Asia in early 2003 as the first contemporary novel severe acute infectious global health problem. In North America, Toronto experienced the bulk of cases that largely affected health care workers[1]. The Ontario health authorities alerted health care personnel on March 14, 2003 about 4 family members with atypical pneumonia that resulted in two deaths. A province-wide emergency was declared on March 26th, 2003 when it became evident that these cases were the epidemiological link to SARS. The government and health care providers took steps to contain the spread of SARS by enacting infection control procedures, screening and isolating those people who were exposed, and admitting affected personnel, many of whom were health care workers, to special hospital SARS units. The public health precautions proved effective enough that by June 12, 2003 there were no more new cases. During those 3 months 273 people were identified as being confirmed SARS [2] cases. 44 [3] died. Because identification of victims and containment were the orders of the time, medical attention focused upon the features of the acute phase of the illness. They were identified as having new onset of fever, documented elevated temperature, and were likely to have nonproductive cough, myalgia, and dyspnea. Such individuals may have been exposed to patients who had traveled to a location known to harbour such cases, i.e., South China, South East Asia, or may have acquired these symptoms as the result of direct contact or exposure [1, 4]. Subsequently a novel coronavirus was identified as the cause of the acute outbreak [5–7]. Although the epidemic in Toronto was considered controlled because no new cases appeared after June 2003 with no one remaining in quarantine [1, 8] one year later when life in the hospitals and city had returned to normal, a cohort of post-SARS patients remained disabled and unable to return to their work. They complained of persisting debilitating physical symptoms including variable musculoskeletal pain, profound weakness, easy fatigability, shortness of breath that accompanied psychological distress and major sleep problems. Because of the possibility of persistence of sleep-related respiratory dysfunction and arousal disturbances in the sleep EEG that could affect daytime fatigue and mood disturbances in the patients with the greatest clinical sleep disturbances, we examined their sleep physiology and coincident somatic and psychological symptoms. This is the first report of the long-term adverse effects of SARS on sleep and somatic symptoms. METHODS The University Health Network human research ethics board approved the retrospective study of clinically necessary sleep studies, and signed informed consent forms were obtained from all patients. 19 females (mean age 46.29 +/- 11.02y., BMI = 28.26 +/- 6.88) and 3 males, (all except one being health care workers) were assessed about 19.8 months after onset of the acute SARS illness (range: 13 to 36 months) with hospitalization and/or quarantine for SARS. They were part of a cohort of 50 post-SARS patients who had come under the care of the Ontario Workers' Safety and Insurance Board (WSIB) because of persistent impaired health that interfered with their hospital work capabilities. They had been sent by WSIB for a complex, intense, interdisciplinary clinical program of physical and psychological restorative rehabilitation. This post-SARS group was compared to a small group of younger healthy 8 females (mean age 30 +/- 6.7 y., p = 0.0002), but with a similar BMI (24.8 +/- 6.1, p =.242) by employing standard self-ratings of physical symptoms [the Wahler Physical Symptom Inventory (WPSI)] [9], of depression [Beck Depression Inventory (BDI)] [10, 11], of self rated symptoms of post traumatic stress disorder (PTSD) because of their exposure to the threat of death as the result of their exposure to the SARS virus[PTSD check list civilian version {PCL-C}] [12], and of sleep symptoms [the Sleep Assessment Questionnairec (SAQc)] [13]. The SAQ is a 17-item questionnaire that has been found to be useful for identifying sleep disorders related to chronic fatigue. One overnight polysomnography was employed in order to objectively evaluate sleep physiology. The procedures included electroencephalogram (EEG C3, C4) electro-oculogram, submental and bilateral anterior tibialis electromyogram, single anterior lead electrocardiogram, measures of respiration comprising measures of airflow with oral-nasal thermistors and respiratory impedance plethysomography, and pulse oximetry. An experienced registered polysomnographic technologist completed blind ratings of sleep physiological indices [14] and standardized ratings (1 to 5) of the presence of a measure of arousal in the non rapid eye movement sleep EEG (NonREM sleep), known as the alpha frequency anomaly [15] where 1 was the percentage of alpha EEG in Non REM sleep (7.5 Hz to 12Hz) less than 20% and where 5 was more than 80% of alpha EEG in Non REM sleep. In order to evaluate daytime lethargy the overnight sleep study was followed by the multiple sleep latency test (MSLT) comprising of at least four 20 minute nap opportunities at 2 hour interval beginning 2 hours after morning awakening [16]. Self ratings of symptoms pre-sleep and post sleep consisted of standard measures of total regional musculoskeletal pain severity (0-24), of fatigue (1-7) [17], and sleepiness [18] that had been used in previous studies of patients with fibromyalgia syndrome (FMS) and chronic fatigue syndrome (CFS). Because clinically the

Read the complete text